https://www.zacks.com/stock/news/2199865/cvs-health-cvs-new-opportunities-drive-growth-macro-woes-stay?cid=CS-ZC-FT-analyst_blog|zer_report_update-2199865
Dec 19, 2023 - CVS Health's (CVS) restructuring plan poises it well, along with its strategic buyouts.
zc:-4107263647690359248
0
https://www.cnbc.com/2023/12/17/top-wall-street-analysts-favor-these-3-dividend-stocks-for-the-long-haul.html
Dec 17, 2023 - TipRanks' analyst ranking service pinpoints Wall Street's best-performing stocks, including CVS Health and Devon Energy.
0
cnbc:-1767599334429761374
0
https://seekingalpha.com/article/4658144-cvs-health-riskreward-highly-skewed-to-the-upside?source=feed_tag_editors_picks
Dec 15, 2023 - CVS Health is transforming into a fully integrated health care provider, with potential for growth and a target price of $100. Learn more on CVS stock here.
0
sa:-8146926531948949176
0
https://www.cnbc.com/2023/12/07/us-retail-lobbyists-retract-key-claim-on-organized-retail-crime-accounting-for-inventory-losses.html
Dec 08, 2023 - The National Retail Federation walked back a claim that organized retail crime accounted for nearly half of all shrink losses because the data point was flawed.
0
cnbc:-5156567211515349336
0
https://seekingalpha.com/news/4044586-why-did-walgreens-boots-stock-go-up-today-cvs-2024-guidance?source=feed_sector_healthcare
Dec 07, 2023 - Walgreens Boots Alliance (WBA) gains as CVS Health's (CVS) bullish 2024 guidance boosts the drug store industry. Read more here.
0
sa:2364185055671441740
0
https://www.fool.com/investing/2023/12/06/why-cvs-stock-rallied-wednesday-morning/?source=iedfolrf0000001
Dec 06, 2023 - Wall Street is warming up to the prospects of the healthcare giant.
0
fool:-9013324529122670424
0
https://www.fool.com/investing/2023/12/05/why-cvs-health-jumped-nearly-4-today/?source=iedfolrf0000001
Dec 05, 2023 - The drugstore chain's 2024 results should be better than most were expecting.
0
fool:6433857311713549729
0
https://www.cnbc.com/2023/12/05/cvs-to-change-how-it-prices-prescription-drugs.html
Dec 05, 2023 - CVS's new effort aims to do away with a complex model that typically determines how much pharmacies get reimbursed and how much patients pay for medications.
0
cnbc:6123376712088928190
0
https://seekingalpha.com/news/4043503-goodrx-stock-falls-cvs-unveils-new-drug-pricing-model?source=feed_sector_healthcare
Dec 05, 2023 - Shares of GoodRx Holdings (GDRX) fell after CVS Health (CVS) announced plans to launch a simpler, cost-based drug pricing method called CostVantage. Read more here.
0
sa:5441109271453692788
0